Found 95 matching trials
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE PHASE4 The objectives of the study were:
1. To assess the safety and tolerability...
Show More Location
Allergy, Asthma and Immunology Associates
Learn More & Join Trial
A Gene Therapy Study of BMN 331 in Subjects With Hereditary Angioedema PHASE1 This is a Phase 1/2, single-arm, open-label, dose-escalation and dose-expan...
Show More Status
Active Not Recruiting
Location
AllerVie Clinical Research
Learn More & Join Trial
A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor PHASE1 A new formulation of Berinert (CSL830) is being investigated for the manage...
Show More Learn More & Join Trial
Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients PHASE3 This is a double-blind, randomized-withdrawal, placebo-controlled study in ...
Show More Location
University of Alabama Hospital (at Birmingham)
Learn More & Join Trial
A Study to Review the Treatment and Outcomes of Teenagers and Adults With Non-histaminergic Angioedema With Normal C1 Inhibitor in Canada N/A The main aim of this study is to describe the characteristics of participan...
Show More Location
Alberta Health Services
Learn More & Join Trial
C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks PHASE3 The study objective was to determine the safety and efficacy of C1INH-nf fo...
Show More Location
Allergy and Immunology Associates
Learn More & Join Trial
EAP for Deucrictibant Immediate-release N/A This is an expanded access program (EAP) designed to allow access to deucri...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration PHASE2 Hereditary angioedema ("HAE") is a disease characterized by recurrent tissu...
Show More Location
For information on sites, please contact Pharming Technologies
Learn More & Join Trial
A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection PHASE2 The purpose of this research study is to evaluate the safety, effect, and p...
Show More Location
ViroPharma Investigative Site
Learn More & Join Trial
A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema PHASE3 The aim of this study is to assess the long-term safety of C1-esterase inhi...
Show More Learn More & Join Trial